FERNANDO
MARTÍNEZ SAGASTI
Profesor asociado de Ciencias de la Salud
University of Cambridge
Cambridge, Reino UnidoUniversity of Cambridge-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
The Lancet Respiratory Medicine, Vol. 11, Núm. 10, pp. 894-904